Background Image
Table of Contents Table of Contents
Previous Page  92 / 492 Next Page
Information
Show Menu
Previous Page 92 / 492 Next Page
Page Background

S4-16

(P)

VOIDING CYSTOURETROGRAPHY AFTER SURGICAL TREATMENT OF

VESICOURETERAL REFLUX: REWARDING OR PUNISHING?

Serhat GÜROCAK

1

, özgür TAN

1

, Cenk ACAR

2

, Iyimser ÜRE

3

, Irfan ATAY

1

, Esat AK

1

and Zafer SINIK

4

1) Gazi University Faculty of Medicine, Urology, Ankara, TURKEY - 2) Acibadem University Faculty of Medicine, Urology,

Istanbul, TURKEY - 3) Osmangazi university faculty of medicine, Urology, Eskisehir, TURKEY - 4) Pamukkale University

Faculty of Medicine, Urology, Denizli, TURKEY

PURPOSE

To investigate the usefulness of postoperative voiding cystouretrography(VCUG) in daily clinical practice after

endoscopic subureteral injection and ureteral re-implantation for vesicoureteral reflux.

MATERIAL AND METHODS

The records of the patients who underwent endoscopic subureteral injection and ureteral re-implantation for

vesicoureteral reflux at two academic centers were reviewed between 2009-2012. The patients were classified as low,

moderate and high-risk groups according to EAU paediatric urology guideline by using VCUG grade, presence of kidney

abnormality, lower urinary tract symptoms and toilet training. Postoperative clinical course, causes of failure,

intervention type, presence of postoperative VCUG were analyzed.

RESULTS

Surgical interventions were performed on 232 renal units(RU) in 159 patients. Mean age of the children was 6.78±5.5

years. 46(19.8%)RU’s were grouped as low-risk, 144 (62.1%) RU’s were moderate risk and 42(18.1%)RU’s were high-

risk. Distribution of postoperative VCUG and presence of urinary tract infection(UTI) were listed in table 1. In moderate

risk group who received subureteral injection; out of 57 RU’s, 5(8.8%)RUs had UTI. Among these, only 1(1.7%)

refluxing RU had UTI(p=0,880). In high risk group, out of 10 RU’s who received VCUG, 1(10%)RU had both reflux and

UTI(p=0,197). In re-implantation group, out of 37RU’s, only 1(%)RU had UTI without reflux.

EAU guideline

Risk grouping

Injection

Ureteral Reimplantation

UTI

P

UTI

P

Positive Negative

Positive Negative

Low risk Group

Postop.VCUGpositive 1(%8.3) 11(%91.7)

0,768

Postop.VCUGnegative 2(%5.9) 32(%94.1)

Moderate risk Group

Postop.VCUGpositive 5(%8.8) 52(%91.2)

0,519

1(%20) 4(%80)

0,097

Postop.VCUGnegative 4(%5.8) 65(%94.2)

0

13(%100)

High Risk Group

Postop.VCUGpositive 1(%10) 9(%90)

0,244

0

7(%100)

Postop.VCUGnegative 0

13(%100)

0

12(%100)

CONCLUSIONS

The application of VCUG for postoperative evaluation didn’t give an extra clue to identify those patients at risk of further

surgical intervention in both groups. The results showed that follow-up after surgical intervention might be set on clinical

outcomes rather than VCUG.